With one of the vast network of life sciences professionals and clientele ranging from research scientists to pharmaceutical companies and hospitals, Areness led by one of its top management hailing from a biomedicine background has a keen affinity towards this sector. Patents to licensing, protection from regulatory action to international trade, we provide end to end support to the said sector.
Understanding the demands of the sector, we guide through the process of mandatory approvals from various statutory authorities and also protect the intellectual property globally. We also assist in licensing, leasing, labelling and other compliances. We guide our clients through reporting of new guidelines, taking safety measures to avoid regulatory action and work with intermediaries for extensive coverage.
The Insolvency and Bankruptcy Code, 2016 (‘Code’) was incorporated with the aim to facilitate speedy debt resolution process and balance of interest of the all the stakeholders.Download
‘Quando aliquid prohibetur ex directo, prohibetur et per obliquum’, meaning what cannot be done directly, cannot be done indirectly,Download
The enactment of the Insolvency & Bankruptcy Code, 2016 (‘Code’) introduced a revamped regime for the liquidation of companies for which insolvency resolution has failed.Download